Reducing tobacco-related harm: FDA's proposed product standard for smokeless tobacco

Micah L. Berman, Dorothy K. Hatsukami

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

This Special Communication discusses the Food and Drug Administration's (FDA's) proposed rule that would limit N-nitrosonornicotine (NNN) levels in smokeless tobacco products. It argues that finalising and implementing this first 'product standard' would mark a significant step forward in the FDA's efforts to reduce tobacco-related harms.

Original languageEnglish (US)
Pages (from-to)352-354
Number of pages3
JournalTobacco control
Volume27
Issue number3
DOIs
StatePublished - May 1 2018

Bibliographical note

Publisher Copyright:
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Keywords

  • Non-cigarette tobacco products
  • harm reduction
  • public policy

Fingerprint

Dive into the research topics of 'Reducing tobacco-related harm: FDA's proposed product standard for smokeless tobacco'. Together they form a unique fingerprint.

Cite this